We collected information about Biovie Inc Hours for you. Follow the liks to find out everything about Biovie Inc Hours.
https://www.nasdaq.com/market-activity/stocks/bivi/after-hours
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET).
https://newsheater.com/2021/10/27/biovie-inc-bivi-reveals-an-earnings-mystery/
BioVie Inc. (NASDAQ:BIVI) went up by 21.61% from its latest closing price compared to the recent 1-year high of $46.10. The company’s stock price has collected 11.04% of gains in the last five trading sessions. Press Release reported 15 hours ago that BioVie Announces FDA Authorization to Initiate Phase 2 Trials Assessing NE3107’s Pro-motoric Activity in Parkinson’s Disease
https://finance.yahoo.com/quote/BIVI/
BioVie Inc. Analyst Report: Pfizer Inc. Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales).
https://finance.yahoo.com/news/biovie-announces-appointment-chief-medical-120000303.html
RENO, Nev., Nov. 01, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (Nasdaq: BIVI), a clinical-stage company developing innovative drug therapies for the treatment of liver disease and neurodegenerative ...
https://www.barrons.com/market-data/stocks/bivi/financials
BioVie, Inc. is a biopharmaceutical company, which discovers, develops and commercializes drug therapies for liver disease. It focuses on …
https://www.msn.com/en-us/money/stockdetails/fi-a29ufr
After Hours : ---November 15, 2021 10:44 AM EST. NLS Real-Time Price. Currency In USD ... BioVie Inc. Class A Common Stock (BIVI) Nasdaq 10/29/2019. BioVie Announces the Appointment of a New Chief ...
https://www.marketwatch.com/story/biovie-gets-fda-approval-to-start-trial-for-parkinson-s-treatment-271635251922
BioVie Inc. said the U.S. Food and Drug Administration has authorized the company to initiate a Phase 2 study assessing NE3107's potential pro-motoric impact in …
https://www.nasdaq.com/press-release/biovie-commences-patient-screening-in-phase-2-clinical-trial-2021-03-09
--BioVie Inc., a clinical-stage company developing innovative drug therapies for liver disease, today announced the start of patient screening in the Company’ s …
https://www.marketwatch.com/story/biovie-shares-rise-24-after-fda-approves-phase-2-study-271635268911
BioVie Inc. shares were up 24% to $6.75 after the company said the U.S. Food and Drug Administration has authorized the company to initiate a Phase 2 …
Searching for Biovie Inc Hours?
You can just click the links above. The info is collected for you.
